World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as pf Jan-05-2024.

World Top Biopharmaceutical Companies 2024
World Largest Biopharmaceutical Companies by Market Cap in 2024, World Top Biopharmaceutical Companies by Market Cap in 2024.

  1. Vitaspring Biomedical Co. Ltd.

    World Rank (Jan-05-2024)
    4,276
    Market Cap (Jan-05-2024)
    3.098 Billion USD
    World Rank (Jul-30-2023)
    4,065
    Market Cap (Jul-30-2023)
    3.304 Billion USD
    World Rank (Dec-25-2022)
    4,081
    Market Cap (Dec-25-2022)
    2.995 Billion USD
    Headquarters Country
    USA
    Company Profile

    Vitaspring Biomedical Co. Ltd. is a Biomedical company. Vitaspring Biomedical Co. Ltd. focuses on the development of drugs of cell medicine. The company was formerly known as Shemn Corp. and changed its name to Vitaspring Biomedical Co. Ltd. Headquarters is in USA.

    The Company produces products for bones, ear, hair, scalp, skin, and other related body parts.

    Vitaspring Biomedical Co. Ltd. Annual Revenue in 2022 was 5 Million USD and it's Total Net Income was in 2022 was 1 Million USD.

     

    Company Website
    VITASPRING BIOMEDICAL CO. LTD.

  3. Guardant Health

    World Rank (Jan-05-2024)
    4,291
    Market Cap (Jan-05-2024)
    3.083 Billion USD
    World Rank (Jul-30-2023)
    3,217
    Market Cap (Jul-30-2023)
    4.547 Billion USD
    World Rank (Dec-25-2022)
    4,241
    Market Cap (Dec-25-2022)
    2.858 Billion USD
    World Rank (Jan-07-2022)
    2,054
    Market Cap (Jan-07-2022)
    8.93 Billion USD
    Annual Revenue in USD
    449 Million USD
    Annual Operating Income in USD
    -544 Million USD
    Annual Net Income in USD
    -654 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    GUARDANT HEALTH is Healthcare sector company related to research related to Cancer treatment. Headquarters is in California, USA.

    Company Website
    GUARDANT HEALTH

  4. Bayer CropScience

    World Rank (Jan-05-2024)
    4,400
    Market Cap (Jan-05-2024)
    2.980 Billion USD
    World Rank (Jul-30-2023)
    5,094
    Market Cap (Jul-30-2023)
    2.398 Billion USD
    World Rank (Dec-25-2022)
    4,553
    Market Cap (Dec-25-2022)
    2.600 Billion USD
    World Rank (Jan-07-2022)
    4,879
    Market Cap (Jan-07-2022)
    2.97 Billion USD
    Annual Revenue in USD
    573 Million USD
    Annual Net Income in USD
    81 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    India
    Stock Category
    S&P BSE BASIC MATERIALS
    Yahoo @ BSE
    Company Profile
    Bayer Crop Science is a Biotechnology company providing farmers with the best tools and solutions so they can achieve better harvests using less water, land and energy. The company total assets 29 billion INR. The headquarters is in India.
    Company Website
    Bayer Crop Science
    Wikipedia
    Wikipedia

  5. Arcellx Inc.

    World Rank (Jan-05-2024)
    4,574
    Market Cap (Jan-05-2024)
    2.827 Billion USD
    World Rank (Jul-30-2023)
    6,599
    Market Cap (Jul-30-2023)
    1.600 Billion USD
    World Rank (Dec-25-2022)
    6,914
    Market Cap (Dec-25-2022)
    1.379 Billion USD
    Headquarters Country
    USA
    Company Profile
    Arcellx is a biotechnology company with one specific mission that is Advance humanity by engineering cell therapies that are safer, more effective and more broadly accessible. The headquarters is in USA.
    Company Website
    ARCELLX, INC.

  6. Springworks Therapeutics

    World Rank (Jan-05-2024)
    4,628
    Market Cap (Jan-05-2024)
    2.777 Billion USD
    World Rank (Jul-30-2023)
    5,906
    Market Cap (Jul-30-2023)
    1.912 Billion USD
    World Rank (Dec-25-2022)
    6,680
    Market Cap (Dec-25-2022)
    1.453 Billion USD
    World Rank (Jan-07-2022)
    5,145
    Market Cap (Jan-07-2022)
    2.76 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -280 Million USD
    Annual Net Income in USD
    -277 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    SpringWorks Therapeutics is a clinical-stage targeted oncology company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from severe rare diseases and cancer. Headquarters is in Connecticut, USA.
    Company Website
    SPRINGWORKS THERAPEUTICS

  7. TG Therapeutics

    World Rank (Jan-05-2024)
    4,673
    Market Cap (Jan-05-2024)
    2.728 Billion USD
    World Rank (Jul-30-2023)
    4,415
    Market Cap (Jul-30-2023)
    2.943 Billion USD
    World Rank (Dec-25-2022)
    7,601
    Market Cap (Dec-25-2022)
    1.180 Billion USD
    World Rank (Jan-07-2022)
    5,472
    Market Cap (Jan-07-2022)
    2.50 Billion USD
    Annual Revenue in USD
    3 Million USD
    Annual Operating Income in USD
    -193 Million USD
    Annual Net Income in USD
    -198 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile
    TG Therapeutics is a Biopharmaceutical company. The company annual revenue is less than 1 million USD and 217 employees. The headquarters is in USA.
    Company Website
    TG THERAPEUTICS

  8. Myovant Sciences

    World Rank (Jan-05-2024)
    4,776
    World Rank (Jul-30-2023)
    4,776
    Market Cap (Jul-30-2023)
    2.620 Billion USD
    World Rank (Dec-25-2022)
    4,545
    Market Cap (Dec-25-2022)
    2.608 Billion USD
    World Rank (Jan-07-2022)
    8,121
    Market Cap (Jan-07-2022)
    1.29 Billion USD
    Annual Revenue in USD
    271 Million USD
    Annual Net Income in USD
    -241 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    UK
    Company Profile

    Myovant Sciences is a biopharmaceutical company. It works for women and for men through purpose driven science, Empowering Medicines and Transformative Advocacy company. It have three clinical programs for relugolix which consisted of five international phase 3 clinical trials, two in women with heavy menstrual bleeding associated with uterine fibroids, two in women with endometriosis associated pain and one in men with advanced prostate cancer. The headquarters is in UK.

    Sumitovant Biopharma acquired Myovant Sciences for 1.7 billion USD in 2023.

    Company Website
    MYOVANT SCIENCES LTD.

  9. Zai Lab

    World Rank (Jan-05-2024)
    4,807
    Market Cap (Jan-05-2024)
    2.622 Billion USD
    World Rank (Jul-30-2023)
    4,184
    Market Cap (Jul-30-2023)
    3.176 Billion USD
    World Rank (Dec-25-2022)
    4,923
    Market Cap (Dec-25-2022)
    2.320 Billion USD
    World Rank (Jan-07-2022)
    3,121
    Market Cap (Jan-07-2022)
    5.31 Billion USD
    Annual Revenue in USD
    144 Million USD
    Annual Net Income in USD
    -704 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ Nasdaq
    Company Profile
    Zai Lab is an Innovative and Research Based Commercial Stage Biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. It is having 900 employees as on 2020. The headquarters is in China.
    Company Website
    ZAI LAB LIMITED

  10. CymaBay Therapeutics

    World Rank (Jan-05-2024)
    4,829
    Market Cap (Jan-05-2024)
    2.607 Billion USD
    World Rank (Jul-30-2023)
    7,868
    Market Cap (Jul-30-2023)
    1.197 Billion USD
    World Rank (Dec-25-2022)
    12,906
    Market Cap (Dec-25-2022)
    0.464 Billion USD
    World Rank (Jan-07-2022)
    17,152
    Market Cap (Jan-07-2022)
    0.28 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -93 Million USD
    Annual Net Income in USD
    -106 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile
    CymaBay Therapeutics is a Clinical Stage Biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need. The company estimated annual revenue is currently 6.8 million USD per year. The headquarters is in USA.
    Company Website
    CYMABAY THERAPEUTICS

Share